Trying to build a mental model of where grayanotoxin sits compared to things I'm more familiar with. How does it compare mechanistically to kava or alcohol? I understand those are different categories but I'm trying to calibrate the risk profile relative to things I have more experience with. Not looking to combine them — just want a framework.
Different mechanisms entirely, which changes the risk/benefit calculus:
Alcohol (ethanol): GABA-A agonist + NMDA antagonist. CNS depressant. Tolerance develops rapidly. Significant liver toxicity with chronic use. Withdrawal syndrome with dependence. Completely different risk profile from either kava or grayanotoxin.
Kava: Kavalactones modulate GABA-A receptors and voltage-gated sodium channels. Anxiolytic, muscle relaxant, mildly euphoric. Hepatotoxicity concerns with heavy or extract-based use. No significant cardiovascular effects at typical doses.
Grayanotoxin: Voltage-gated sodium channel modulator only. Primary effects are cardiovascular (bradycardia, hypotension) and parasympathetic. No GABA involvement, no liver concerns established, no withdrawal syndrome reported. The risk is acute rather than chronic — the danger is in taking too much at once, not in long-term cumulative use.
Summary: different mechanisms, different risk windows. Grayanotoxin's risk is dose-response at the time of use. Kava and alcohol risks accumulate with chronic patterns.
I switched from kava to mad honey primarily because of the hepatotoxicity concerns with daily kava use. The experience is different but there's some overlap in the 'gentle relaxation' quality. For me the mad honey effect is more physical and cardiovascular — warmth, heaviness, slowing down. Kava is more mentally calming. They don't substitute for each other cleanly, and I don't combine them.